A Variant In the Abo Gene Explains the Variation in Soluble E-Selectin Levels-Results from Dense Genotyping in Two Independent Populations

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Karakas, Mahir ^a   Baumert, Jens ^b   Kleber, Marcus E ^a,c   Thorand, Barbara ^b   Dallmeier, Dhayana ^a   Silbernagel, Günther ^d   Grammer, Tanja B ^c   Rottbauer, Wolfgang ^a   Meisinger, Christa ^b   Illig, Thomas ^b,e   März, Winfried ^c,f,g   Koenig, Wolfgang ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f MEDICAL UNIVERSITY OF GRAZ   (Austria)

^g SYNLAB ACADEMY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1;

ABO GENE; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD GROUP ABO SYSTEM; CAUCASIAN; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; E-SELECTIN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GERMANY; HUMANS; MALE; MICE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; YOUNG ADULT;

EID: 84871692516     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051441     Document Type: Article

References (26)

1. Hansson GK, (2005) Inflammation, atherosclerosis and coronary artery disease. N Engl J Med 352: 1685-1695.
2. Leeuwenberg JF, Smeets EF, Neefjes JJ, Shaffer MA, Cinek T, et al. (1992) E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology 77: 543-549.
3. Meigs JB, Hu FB, Rifai N, Manson JE, (2004) Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 28: 1978-1986.
4. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, et al. (1997) Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 96: 4219-4225.
5. Kiechl S, Paré G, Barbalic M, Qi L, Dupuis J, et al. (2011) Association of variation at the ABO locus with circulating levels of soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin: a meta-analysis. Circ Cardiovasc Genet 4: 681-686.
6. Löwel H, Döring A, Schneider A, Heier M, Thorand B, et al. (2005) The MONICA Augsburg surveys-basis for prospective cohort studies. Gesundheitswesen 67Suppl 1: 13-18.
7. Koenig W, Karakas M, Zierer A, Herder C, Baumert J, et al. (2011) Oxidized LDL and the risk of coronary heart disease: results from the MONICA/KORA Augsburg Study. Clin Chem 57: 1196-1200.
8. Karakas M, Koenig W, Zierer A, Herder C, Rottbauer W, et al. (2012) Myeloperoxidase is associated with incident coronary heart disease independently of traditional risk factors: results from the MONICA/KORA Augsburg study. J Intern Med 271: 43-50.
9. Thorand B, Kolb H, Baumert J, Koenig W, Chambless L, et al. (2005) Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002. Diabetes 54: 2932-2938.
10. Winkelmann BR, März W, Boehm BO, Zotz R, Hager J, et al. (2001) Rationale and design of the LURIC study-a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2(1Suppl 1): 1-73.
11. World Medical Association Declaration of Helsinki, Ethical Principles for Medical Research involving human subjects. Available: http://www.laakariliitto.fi/e/ethics/helsinki.html. Accessed: 2012 Nov 22.
12. Herder C, Baumert J, Zierer A, Roden M, Meisinger C, et al. (2011) Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study. PLoS ONE 6: e19852.
13. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, et al. (2007) PLINK: a toolset for whole-genome association and population-based linkage analysis. American Journal of Human Genetics 81: 559-575.
14. Saxena R, Elbers CC, Guo Y, Peter I, Gaunt TR, et al. (2012) Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet 90: 410-425.
15. Lanktree MB, Guo Y, Murtaza M, Glessner JT, Bailey SD, et al. (2012) Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. Am J Hum Genet 88: 6-18.
16. Yamamoto F, Clausen H, White T, Marken J, Hakomori A, (1990) Molecular genetic basis of the histo-blood group ABO system. Nature 345: 229-233.
17. Yamamoto F, McNeill PD, Hakomori S, (1992) Human histo-blood group A2 transferase coded by A2 allele, one of the A subtypes, is characterized by a single base deletion in the coding sequence, which results in an additional domain at the carboxyl terminal. Biochem Biophys Res Commun 187: 366-374.
18. Barbalic M, Dupuis J, Dehghan A, Bis JC, Hoogeveen RC, et al. (2010) Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet 19: 1863-1872.
19. Ho M, Hickey MJ, Murray AG, Andonegui G, Kubes P, (2000) Visualization of Plasmodium falciparum -endothelium interactions in human microvasculature: mimicry of leukocyte recruitment. J Exp Med 192: 1205-1211.
20. Wu O, Bayoumi N, Vickers MA, Clark P, (2008) ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 6: 62-69.
21. Reilly MP, Li M, He J, Ferguson JF, Stylianou IM, et al. (2011) Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 377: 383-392.
22. Schunkert H, König IR, Kathiresan S, Reilly MP, Assimes TL, et al. (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43: 333-338.
23. Qi L, Cornelis MC, Kraft P, Jensen M, van Dam RM, et al. (2010) Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes. Hum Mol Genet 19: 1856-1862.
24. Trégouët DA, Heath S, Saut N, Biron-Andreani C, Schved JF, et al. (2009) Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood 113: 5298-5303.
25. Smith NL, Chen MH, Dehghan A, Strachan DP, Basu S, et al. (2010) Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation 121: 1382-1392.
26. Chasman DI, Paré G, Mora S, Hopewell JC, Peloso G, et al. (2009) Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. PLoS Genet 5: e1000730.